Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility. Diabetes March 1992 41:378-384; doi:10.2337/diabetes.41.3.378
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Diabetes March 1992 41:347-353; doi:10.2337/diabetes.41.3.347
Multiple TCR V beta usage by infiltrates of young NOD mouse islets of Langerhans. A polymerase chain reaction analysis. Diabetes March 1992 41:308-312; doi:10.2337/diabetes.41.3.308
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Diabetes March 1992 41:347-353; doi:10.2337/diabetes.41.3.347
Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study. Diabetes March 1992 41:313-317; doi:10.2337/diabetes.41.3.313
Insulin and insulinlike growth factors in embryonic development. Effects of a biologically inert insulin (guinea pig) on rat
embryonic growth and development in vitro. Diabetes March 1992 41:318-324; doi:10.2337/diabetes.41.3.318
Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study. Diabetes March 1992 41:313-317; doi:10.2337/diabetes.41.3.313
Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and
obese rats. Diabetes March 1992 41:294-298; doi:10.2337/diabetes.41.3.294
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Diabetes March 1992 41:347-353; doi:10.2337/diabetes.41.3.347
Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes March 1992 41:255-260; doi:10.2337/diabetes.41.3.255
Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility. Diabetes March 1992 41:378-384; doi:10.2337/diabetes.41.3.378
Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility. Diabetes March 1992 41:378-384; doi:10.2337/diabetes.41.3.378
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Diabetes March 1992 41:347-353; doi:10.2337/diabetes.41.3.347
Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients
with NIDDM. Diabetes March 1992 41:354-358; doi:10.2337/diabetes.41.3.354
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Diabetes March 1992 41:347-353; doi:10.2337/diabetes.41.3.347
Insulin and insulinlike growth factors in embryonic development. Effects of a biologically inert insulin (guinea pig) on rat
embryonic growth and development in vitro. Diabetes March 1992 41:318-324; doi:10.2337/diabetes.41.3.318
Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of
antihypertensive therapy. Diabetes March 1992 41:286-293; doi:10.2337/diabetes.41.3.286
Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes. Effects on glucose transporter
gene expression. Diabetes March 1992 41:274-285; doi:10.2337/diabetes.41.3.274
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Diabetes March 1992 41:347-353; doi:10.2337/diabetes.41.3.347
Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients
with NIDDM. Diabetes March 1992 41:354-358; doi:10.2337/diabetes.41.3.354
Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study. Diabetes March 1992 41:313-317; doi:10.2337/diabetes.41.3.313
Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility. Diabetes March 1992 41:378-384; doi:10.2337/diabetes.41.3.378
Insulin and insulinlike growth factors in embryonic development. Effects of a biologically inert insulin (guinea pig) on rat
embryonic growth and development in vitro. Diabetes March 1992 41:318-324; doi:10.2337/diabetes.41.3.318
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Diabetes March 1992 41:347-353; doi:10.2337/diabetes.41.3.347
Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility. Diabetes March 1992 41:378-384; doi:10.2337/diabetes.41.3.378
Insulin and insulinlike growth factors in embryonic development. Effects of a biologically inert insulin (guinea pig) on rat
embryonic growth and development in vitro. Diabetes March 1992 41:318-324; doi:10.2337/diabetes.41.3.318
Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma. Diabetes March 1992 41:359-367; doi:10.2337/diabetes.41.3.359
Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma. Diabetes March 1992 41:359-367; doi:10.2337/diabetes.41.3.359
Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility. Diabetes March 1992 41:378-384; doi:10.2337/diabetes.41.3.378
Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and
obese rats. Diabetes March 1992 41:294-298; doi:10.2337/diabetes.41.3.294
Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma. Diabetes March 1992 41:359-367; doi:10.2337/diabetes.41.3.359
Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes. Effects on glucose transporter
gene expression. Diabetes March 1992 41:274-285; doi:10.2337/diabetes.41.3.274
Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes. Effects on glucose transporter
gene expression. Diabetes March 1992 41:274-285; doi:10.2337/diabetes.41.3.274
Multiple TCR V beta usage by infiltrates of young NOD mouse islets of Langerhans. A polymerase chain reaction analysis. Diabetes March 1992 41:308-312; doi:10.2337/diabetes.41.3.308
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for
C-peptide clearance. Diabetes March 1992 41:368-377; doi:10.2337/diabetes.41.3.368
Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study. Diabetes March 1992 41:313-317; doi:10.2337/diabetes.41.3.313
Multiple TCR V beta usage by infiltrates of young NOD mouse islets of Langerhans. A polymerase chain reaction analysis. Diabetes March 1992 41:308-312; doi:10.2337/diabetes.41.3.308
Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of
antihypertensive therapy. Diabetes March 1992 41:286-293; doi:10.2337/diabetes.41.3.286
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for
C-peptide clearance. Diabetes March 1992 41:368-377; doi:10.2337/diabetes.41.3.368
Insulin and insulinlike growth factors in embryonic development. Effects of a biologically inert insulin (guinea pig) on rat
embryonic growth and development in vitro. Diabetes March 1992 41:318-324; doi:10.2337/diabetes.41.3.318
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Diabetes March 1992 41:347-353; doi:10.2337/diabetes.41.3.347
Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma. Diabetes March 1992 41:359-367; doi:10.2337/diabetes.41.3.359
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Diabetes March 1992 41:347-353; doi:10.2337/diabetes.41.3.347
Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and
obese rats. Diabetes March 1992 41:294-298; doi:10.2337/diabetes.41.3.294
Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Diabetes March 1992 41:347-353; doi:10.2337/diabetes.41.3.347
Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study. Diabetes March 1992 41:313-317; doi:10.2337/diabetes.41.3.313
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for
C-peptide clearance. Diabetes March 1992 41:368-377; doi:10.2337/diabetes.41.3.368
Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study. Diabetes March 1992 41:313-317; doi:10.2337/diabetes.41.3.313
Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and
obese rats. Diabetes March 1992 41:294-298; doi:10.2337/diabetes.41.3.294
Insulin and insulinlike growth factors in embryonic development. Effects of a biologically inert insulin (guinea pig) on rat
embryonic growth and development in vitro. Diabetes March 1992 41:318-324; doi:10.2337/diabetes.41.3.318
Insulin and insulinlike growth factors in embryonic development. Effects of a biologically inert insulin (guinea pig) on rat
embryonic growth and development in vitro. Diabetes March 1992 41:318-324; doi:10.2337/diabetes.41.3.318
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for
C-peptide clearance. Diabetes March 1992 41:368-377; doi:10.2337/diabetes.41.3.368
Multiple TCR V beta usage by infiltrates of young NOD mouse islets of Langerhans. A polymerase chain reaction analysis. Diabetes March 1992 41:308-312; doi:10.2337/diabetes.41.3.308
Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients
with NIDDM. Diabetes March 1992 41:354-358; doi:10.2337/diabetes.41.3.354
Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of
antihypertensive therapy. Diabetes March 1992 41:286-293; doi:10.2337/diabetes.41.3.286